Family Members At INcreased-risk for Developing Inflammatory Bowel Disease (FIND-IBD)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

First-degree relatives of people with inflammatory bowel disease (IBD, including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected. The anticipated length of the study (registry) is approximately 10 years or longer. Parts of this study, such as the questionnaires and stool and urine collection, may be done from home, while other parts, such as the blood draw, will need to be done from Massachusetts General Hospital.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Healthy Volunteers: t
View:

• Ability to give informed consent

• Ability to complete all study visits and study-related procedures

• Ability to understand and complete study questionnaires

• Must have at least one first-degree relative with inflammatory bowel disease (Crohn's disease, ulcerative colitis, or IBD-unclassified)

• Age ≥ 14

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Emily W Lopes, MD, MPH
mghfindibd@mgb.org
617-726-5560
Time Frame
Start Date: 2024-12-18
Estimated Completion Date: 2034-12
Participants
Target number of participants: 50
Treatments
Individuals who have a parent, sibling, or child with IBD but who do not have IBD themselves
Adult and adolescent (greater than 14 years of age) first-degree relatives (parents, siblings, or children) of patients with inflammatory bowel disease (including Crohn's disease, ulcerative colitis, or inflammatory bowel disease-unclassified/indeterminate colitis) but who do not have inflammatory bowel disease themselves.
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov